Authors

Latest:

Dr. Khan on Retrospective Analysis of Demographics in CRC and Gastric Cancer

Amir Khan, MD, discusses a large retrospective database analysis on colorectal cancer and gastric cancer presented at the 2020 Gastrointestinal Cancers Symposium.

Amira Abdelhamid

Latest:

MicroRNA-34a in Hepatocellular Carcinoma

Amira Abdelhamid, assistant lecturer, German University in Cairo, discusses microRNA-34a and natural killer (NK) cells in hepatocellular carcinoma (HCC).

Amishi Desai, MD

Latest:

Dr. Desai on Immunotherapy in Patients With NSCLC and Low PD-L1 Expression

Amishi Desai, MD, assistant professor of medicine at Upstate University Hospital, discusses the use of immunotherapy in patients with non–small cell lung cancer (NSCLC) with PD-L1 expression less than 1%.

Amit Singal, MD, MS

Latest:

Future Directions in the Management of Hepatocellular Carcinoma

To close, Dr. Saeed and Dr. Singal share their excitement for the future landscape, emerging agents and treatment strategies for patients with HCC.

Amit Gupta, MD

Latest:

Dr. Gupta on the Role of Surgery in Bladder Cancer

Amit Gupta, MD, urologic oncologist, Department of Surgery, Cedars-Sinai Medical Center, discusses how the use of immunotherapy agents is altering the role of surgery in bladder cancer and the need for Bacillus Calmette-Guérin (BCG) alternatives.

Amit K. Verma, MD

Latest:

CD19 CAR T-Cell Therapy Shows Efficacy in Real-World Setting

Investigators at Montefiore showed that axicabtagene-ciloleucel can be used successfully in ethnically diverse patients with high-risk, relapsed/refractory diffuse large B-cell lymphoma at an inner-city hospital.

Amit Mahipal, MBBS

Latest:

Pivotal Trial Results Look to Shake Up HCC Treatment

Hepatocellular cancer, the most common primary liver malignancy, is the fourth-leading cause of cancer-related deaths globally.

Amit Mehta, MD Independent Hematology

Amit Mehta, MD, Premier Hematology

Amit Singal, MD, MS, UT Southwestern Medical Center

Latest:

Challenges of Sequencing and Biomarkers in HCC

Experts provide insight into the challenges of sequencing and biomarkers when treating advanced HCC.

Amit Singal, MD, University of Texas Southwestern Medical Center

Amit Singal, MD, UT Southwestern Medical Center

Latest:

Biomarkers to Guide HCC Treatment Decisions

Professionals who treat patients with hepatocellular carcinoma comment on the need for more research and biomarkers to fuel treatment decisions.

Amitabh Chak, MD

Latest:

Dr. Chak on Challenges With Screening For Esophageal Cancer

Amitabh Chak, MD, professor of Medicine, Gastroenterology, Case Western Reserve University School of Medicine, discusses challenges with screening patients for Barrett's esophagus and esophageal cancer.

Amitabh Gulati, MD

Latest:

Update on the Management of Pain in Patients With Advanced Cancer

In the United States in 2010, it was estimated that there were more than 1.5 million new cancer cases and 569,490 deaths from cancer.

Amol K. Narang, MD

Latest:

Dr. Narang Discusses Role of Radiation in Pancreatic Cancer

Amol K. Narang, MD, assistant professor of radiation oncology and molecular radiation sciences, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins Medicine, discusses the role of radiation therapy in the treatment of patients with pancreatic cancer.

Amrita Krishan, MD, City of Hope Comprehensive Cancer Center

Amrita Krishnan, MD

Latest:

Dr Krishnan on the Optimal Use of DKd in Relapsed/Refractory Multiple Myeloma

Amrita Krishnan, MD, discusses the role of DKd for patients with relapsed/refractory multiple myeloma.

Amrita Krishnan, MD, City of Hope Comprehensive Cancer Center

Amrita Krishnan, MD, FACP, City of Hope Cancer Center

Amrita Y. Krishnan, MD, City of Hope Comprehensive Cancer Center